In recent years, the lice treatment market is anticipated to grow rapidly during the forecast period. According to a UN survey released in 2019, the number of children under the age of 14 is anticipated to surpass 2.02 billion in 2019 and reach 2.06 billion by 2050. Because of the large number of people who are susceptible to lice infestation, the market is expected to develop. Lice is a parasite that feeds on human blood and thrives primarily on the head or public areas. Most lice treatments must be applied twice, seven to ten days apart, and nits must be removed by combing damp hair with a fine-toothed comb.

Data Bridge Market Research analyses that the lice treatment market was valued at USD 93.47 million in 2021 and is expected to reach USD 156.44 million by 2029, registering a CAGR of 6.65% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Access Full Report: https://www.databridgemarketresearch.com/reports/global-lice-treatm...

Lice are wingless, blood-sucking insects that feed on the blood of humans and live on their heads or scalps. When lice suck blood from people, they inject saliva. Blood coagulation is prevented by injecting saliva. Pruritus is a disease caused by lice saliva entering the human circulatory system. The lice's saliva may trigger severe allergic reactions in some people, and the lice's sharp claws can cause itching and pain by moving through hair strands. Lice treatments (called pediculicides) are accessible without a prescription or over the counter. Shampoos, lotions, and cream rinses are among them.

Opportunities

Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the lice treatment market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the lice treatment market growth during the forecast period.

Restraints/Challenges

On the other hand, high cost high cost associated with the treatment will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the lice treatment market. Additionally, strict regulatory policies and lack of awareness among people will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This lice treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lice treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

In October 2020, U.S. Food and Drug Administration (FDA) had announced the approval of a lotion used in the treatment of head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The prescription drug manufacturer usually initiates the changeover from prescription to over-the-counter. The evidence presented must demonstrate that the drug is safe and effective when used as instructed in the proposed labelling for it to be switched from prescription to nonprescription status. According to the company, consumers must be able to grasp how to use the drug safely and efficiently without the assistance of a healthcare expert.
Lice Treatment Market Scope
The lice treatment market is segmented on the basis of type, treatment, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

Pediculosis Capitis
Pediculosis Corporis
Pediculosis Pubis
Others
Treatment

Ivermectin
Spinosad
Permethrin
Pyrethrin
Other
Dosage form

Tablets
Shampoos
Lotions
Cream
Others
Route of Administration

Oral
Topical
Others
End-Users

Hospitals
Specialty Clinics
Homecare
Others
Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

Some of the major players operating in the lice treatment market are:

F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd.(Israel)
Sanofi (France), Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)
AstraZeneca (UK)
Johnson & Johnson (US)
Bayer AG (Germany)
Sun Pharmaceutical Industries Ltd. (India)
Eli Lilly and Company (US)
Edenbridge Pharmaceuticals, LLC (US)
ParaPRO LLC (US)
Encube Ethicals (India)
GALDERMA (Switzerland)
Alliance Pharmaceuticals (UK)
Foamix Pharmaceuticals Ltd (US)
Arbor Pharmaceuticals (US)
Dr. Reddy's Laboratories Ltd. (India)
Perrigo Company plc (Ireland)